Pelikan Zdenek
Allergy Research Foundation, Breda, The Netherlands.
Int Arch Allergy Immunol. 2009;148(4):330-8. doi: 10.1159/000170387. Epub 2008 Nov 11.
There is a link between the upper and lower airways. Allergic rhinitis and bronchial asthma may coexist, but they can also affect each other.
To investigate the possibility of nasal allergy being able to induce a secondary asthmatic response (AR).
In 82 asthmatics responding insufficiently to standard antiasthmatic therapy and demonstrating negative ARs to bronchial challenge with allergen, 82 nasal challenges with various inhalant allergens were performed by means of rhinomanometry in combination with spirometry (vital capacity and forced expiratory volume in 1 s). In 33 control subjects suffering from allergic rhinitis (n=18) or bronchial asthma (n=15) only, 33 nasal challenges with inhalant allergens were performed by rhinomanometry and supplemented with spirometry.
Of the 82 nasal challenges, 69 produced a positive nasal response (p<0.01) and 13 were negative (p>0.05). In 58 cases with a positive nasal challenge, a secondarily induced AR was recorded (p<0.01). The following types of ARs were documented: 17 isolated immediate ARs (p<0.01), 24 isolated late ARs (p<0.01), 12 dual late ARs (immediate + late, p<0.05 and p<0.01, respectively) and 5 isolated delayed ARs (p<0.05).
(1) An allergic reaction occurring initially in the nasal mucosa can play an important role in bronchial asthma by inducing a secondary AR, and (2) nasal challenge with allergen performed by rhinomanometry in combination with lung function recording (e.g. spirometry) may then determine the possible need for additional intranasal antiallergic treatment and sparing of antiasthmatic drugs.
上、下呼吸道之间存在联系。变应性鼻炎和支气管哮喘可能同时存在,而且它们也会相互影响。
探讨鼻过敏诱发继发性哮喘反应(AR)的可能性。
对82例对标准抗哮喘治疗反应不佳且支气管过敏原激发试验显示AR阴性的哮喘患者,采用鼻阻力测量法结合肺量计(肺活量和1秒用力呼气量)对其进行82次不同吸入性过敏原的鼻激发试验。对33例仅患有变应性鼻炎(n = 18)或支气管哮喘(n = 15)的对照受试者,采用鼻阻力测量法进行33次吸入性过敏原鼻激发试验,并辅以肺量计检查。
82次鼻激发试验中,69次产生阳性鼻反应(p < 0.01),13次为阴性(p > 0.05)。在58例鼻激发试验阳性的病例中,记录到继发性AR(p < 0.01)。记录到以下类型的AR:17例孤立的速发AR(p < 0.01),24例孤立的迟发AR(p < 0.01),12例双相迟发AR(速发 + 迟发,分别为p < 0.05和p < 0.01),以及5例孤立的延迟AR(p < 0.05)。
(1)最初发生在鼻黏膜的过敏反应可通过诱发继发性AR在支气管哮喘中起重要作用;(2)采用鼻阻力测量法结合肺功能记录(如肺量计)进行过敏原鼻激发试验,可确定是否可能需要额外的鼻内抗过敏治疗以及减少抗哮喘药物的使用。